Bringing the fundamentals into focus…
Back to RadNet, Inc.
How RadNet, Inc. stacks up
RDNT · against 1,336 other Healthcare companies
Valuation
42/ 100
Below the middle of the pack.
Ranked #770 of 1,337 · scores higher than 42% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including RDNT · Click a bar to see the companies
Why valuation scores 42?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -0.4% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.8% vs peer median 4.0%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.3% vs peer median 0.0%
Metric by metric
Position: dot = RDNT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RDNT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -0.4% | 1.5% | 39% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 3.7% | 4.2% | 47% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 1.3% | -1.0% | 59% | 20% | |
| Book yieldHigher is better · 1,306 reported | 19.0% | 37.9% | 27% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around RDNTScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score